VERICEL CORPORATION

Vericel Corporation specializes in the development and manufacturing of advanced surgical implants and biologic tissue products for orthopedic and regenerative applications. Their core capabilities center on the production of autologous and allogeneic cartilage repair systems, including membrane-based implants and precision-engineered surgical appliances designed for minimally invasive procedures. The company demonstrates deep technical expertise in cell-based tissue engineering, sterile biologic processing, and GMP-compliant manufacturing of implantable medical devices. Key differentiators include proprietary scaffold technologies and end-to-end control over product assembly, ensuring consistent quality for complex regenerative therapies used in joint restoration. Their focus on cartilage regeneration positions them as a niche leader in bioengineered orthopedic solutions. Vericel maintains a sustained and exclusive relationship with the Department of Veterans Affairs, supplying specialized surgical implants and biologic grafts to support veteran musculoskeletal care. Their work for the VA consistently involves high-precision, patient-specific cartilage repair systems and surgical implants used in knee and joint reconstruction, reflecting a trusted, long-term partnership in delivering advanced orthopedic therapies within the VA healthcare network. The company’s primary industry focus lies in surgical appliance and supplies manufacturing (NAICS 339113), with secondary activity in surgical instrument manufacturing (339112) and pharmaceutical preparation (325412). These codes reflect a vertical specialization in regenerative medicine, particularly in the development of implantable biological tissues for cartilage repair and orthopedic reconstruction. Vericel’s market positioning is defined by its role as a manufacturer of clinically validated, FDA-regulated biologic products rather than conventional medical devices or pharmaceuticals. Vericel Corporation is headquartered in Cambridge, Massachusetts, and operates as a privately held entity (Entity Structure: 2L). While no federal certifications are listed, their manufacturing processes adhere to stringent regulatory standards required for implantable biologics. Their geographic presence and operational focus are aligned with the U.S. federal healthcare market, particularly serving veteran-centric care delivery systems.